RxDoctor Payments Data

Ellanikole Jackson

Family · Counce, TNNPI 1932676194

Payments from drug & device makers

$410in general payments, 2019–2025

Across 18 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$158
  • Cvrx, Inc.$81
  • Novo Nordisk$35
  • GSK$29
  • AstraZeneca$21
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$20
  • plus $66 from 4 others

What the payments were for

  • Food & beverage$410100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$410 in reported general payments places this provider in the 45th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$276
Medicare patients
39
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide89$91,337
OzempicSemaglutide82$86,298
Trelegy ElliptaFluticasone/Umeclidin/Vilanter78$50,531
LinzessLinaclotide75$46,082
QuliptaAtogepant19$24,843
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr34$19,660
XareltoRivaroxaban21$15,417
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$15,335
JanuviaSitagliptin Phosphate21$11,909
EliquisApixaban13$10,335
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen362$9,313
EntrestoSacubitril/Valsartan11$7,571
Repatha SureclickEvolocumab13$7,335
Xtampza ErOxycodone Myristate12$6,797
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen198$6,013

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$17$91,33789 claims
Novo NordiskOzempic$35$86,29882 claims
AbbVieLinzess, Qulipta, Synthroid$158$72,374116 claims
GSKTrelegy Ellipta, Anoro Ellipta$29$70,191112 claims
PfizerEliquis$19$10,33513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 6,706 family providers in Tennessee.

Other family in Counce

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →